Table 1 Demographic and clinical data.

From: Combined EEG and immersive virtual reality unveil dopaminergic modulation of error monitoring in Parkinson’s Disease

(a)

 

PD (N = 15)

HCs (N = 14)

 

Mean ± SD

Mean ± SD

p (<0.05)

Sex

10 M, 5 F

9 M, 5 F

n.s. (0.89)

Age

69.93 ± 8.75

69.57 ± 6.06

n.s. (0.90)

Education

11.60 ± 4

13. 07 ± 2.58

n.s (0.25)

MMSE

29.13 ± 0.64

29.07 ± 1

n.s. (0.84)

MMPSE

29.79 ± 2.29

—

 

LEDD

632.83 ± 186.55

—

 

(b)

 

PD on (N = 15)

PD off (N = 15)

 
 

Mean ± SD

Mean ± SD

p (<0.05)

UPDRS-III

17.67 ± 6.80

37.21 ± 10.04

s. (0.0001)

H&Y

2.08 ± 0.18

2.32 ± 0.32

s. (0.02)

  1. (a) Summary of demographics and clinical scores for the PD and HCs groups. age: age in years, education: education in years, MMSE mini-mental state examination, MMPSE mini-mental Parkinson state examination, LEDD levodopa equivalent daily dose.
  2. (b) Summary of motor scale scores (unified PD rating scale, section III [UPDRS-III]) and disease progression (Hoehn and Yahr [H&Y] scale) of PD patients tested on- (with dopaminergic medication) and off-condition (without dopaminergic medication). n.s. non-significant, s significant.
Back to article page